Rapport Therapeutics (RAPP) insider trading in the last 6 months
6 insiders bought $1.7M. No sales.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Form 4 filings, newest first
Not counted as insider buys
Who files at Rapport Therapeutics
Cluster buys at RAPP
6 insiders bought RAPP in the last 6 months: Steven M. Paul, John Maraganore, Troy A. Ignelzi, Wendy B. Young, Paul M. Silva, and Ramiro Sanchez.
Questions about RAPP's insider trades
Are RAPP insiders buying or selling?
6 insiders bought $1.7M across 7 filings in the last 6 months. No open-market sales on record. The newest filing: Ramiro Sanchez, Director, bought $98K on Oct 23, 2026. 6 insiders bought RAPP in the last 6 months: Steven M. Paul, John Maraganore, Troy A. Ignelzi, Wendy B. Young, Paul M. Silva, and Ramiro Sanchez.
Who are RAPP's biggest insider sellers?
No RAPP insider sold shares on the open market in the last 6 months, as filed on Form 4.
When did an RAPP insider last buy?
Ramiro Sanchez, Director, bought RAPP shares ($98K) on Oct 23, 2026, the newest insider buy on record.
Rapport Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. RAPP is on insider buys, Oct 19 to 25, 2026.